MVIS US Listed Pharmaceutical 25 Index ETF Overview

The MVIS US Listed Pharmaceutical 25 Index measures the performance of Health Care securities and is selected by a Market Cap process. Currently, 1 ETF track the MVIS US Listed Pharmaceutical 25 Index with more than $265.1 M in ETP assets with an average expense ratio of 0.35%. The largest ETF is VanEck Vectors Pharmaceutical ETF (PPH) by VanEck with $265.1 M in assets.